Daniel H. White, President and CEO at Clearside Biomedical, Inc. (CLSD), sold 8,000 shares at $9.79 ($78K) on 2017-07-19, disclosed to the SEC on 2017-07-21.
Scheduled sale ($78k) by President and CEO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $9.79 | 400 | $4K | 5.0% |
| 2 | $9.79 | 3,600 | $35K | 45.2% |
| 3 | $9.71 | 400 | $4K | 5.0% |
| 4 | $9.71 | 3,600 | $35K | 44.8% |
| Total | $9.75 avg | 8,000 | $78K | 100% |
| Filing → |
| CLSD | SELL | 2017-09-11 | $121K | — | Filing → |
| CLSD | SELL | 2017-06-14 | $63K | — | Filing → |
| CLSD | SELL | 2017-05-19 | $67K | — | Filing → |